Have a personal or library account? Click to login
Chronopharmacology of high blood pressure—a critical review of clinical evidence Cover

Chronopharmacology of high blood pressure—a critical review of clinical evidence

By: P. Potucek and  J. Klimas  
Open Access
|Jan 2020

References

  1. [1] Asmar R, Gosse P, Quere S, Achouba A. Efficacy of morning and evening dosing of amlodipine/valsartan combination in hypertensive patients uncontrolled by 5 mg of amlodipine. Blood pressure monitoring. 2011 Apr 1;16(2):80-6.10.1097/MBP.0b013e328344c6db21372694
  2. [2] Dahlöf B. Management of cardiovascular risk with RAS inhibitor/CCB combination therapy. Journal of human hypertension. 2009 Feb;23(2):77.10.1038/jhh.2008.8818685606
  3. [3] De La Sierra A, Redon J, Banegas JR, Segura J, Parati G, Gorostidi M, de la Cruz JJ, Sobrino J, Llisterri JL, Alonso J, Vinyoles E. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension. 2009 Mar 1;53(3):466-72.10.1161/HYPERTENSIONAHA.108.12400819171788
  4. [4] Hermida RC, Ayala DE, Fernández JR, Portaluppi F, Fabbian F, Smolensky MH. Circadian rhythms in blood pressure regulation and optimization of hypertension treatment with ACE inhibitor and ARB medications. American journal of hypertension. 2011 Apr 1;24(4):383-9110.1038/ajh.2010.21720930708
  5. [5] Hermida RC, Ayala DE, Fernández JR, Mojón A, Smolensky MH, Fabbian F, Portaluppi F. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation. Chronobiology international. 2013 Mar 1;30(1-2):280-314.10.3109/07420528.2012.70944823077971
  6. [6] Hermida RC, Ayala DE, Fontao MJ, Mojón A, Fernández JR. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing. Chronobiology international. 2010 Jul 1;27(6):1287-303.10.3109/07420528.2010.48916720653455
  7. [7] Hermida RC, Ayala DE, Mojón A, Fernández JR. Chronotherapy with nifedipine GITS in hypertensive patients: improved efficacy and safety with bedtime dosing. American journal of hypertension. 2008 Aug 1;21(8):948-54.10.1038/ajh.2008.21618600215
  8. [8] Kasiakogias A, Tsioufis C, Thomopoulos C, Andrikou I, Aragiannis D, Dimitriadis K, Tsiachris D, Bilo G, Sideris S, Filis K, Parati G. Evening versus morning dosing of antihypertensive drugs in hypertensive patients with sleep apnoea: a cross-over study. Journal of hypertension. 2015 Feb 1;33(2):393-400.10.1097/HJH.000000000000037125318654
  9. [9] Langner B, Lemmer B. Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects. European journal of clinical pharmacology. 1988 Nov 1;33(6):619-24.10.1007/BF005424983366165
  10. [10] Lemmer B. The importance of circadian rhythms on drug response in hypertension and coronary heart disease—from mice and man. Pharmacology & therapeutics. 2006 Sep 1;111(3):629-51.10.1016/j.pharmthera.2005.11.00816480770
  11. [11] Lemmer B, Nold G, Behne S, Kaiser R. Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiology international. 1991 Jan 1;8(6):485-94.10.3109/074205291090591841799930
  12. [12] Liu X, Liu X, Huang W, Leo S, Li Y, Liu M, Yuan H. Evening-versus morning-dosing drug therapy for chronic kidney disease patients with hypertension: a systematic review. Kidney and Blood Pressure Research. 2014;39(5):427-40.10.1159/00036845625471279
  13. [13] Liu Y, Ushijima K, Ohmori M, Takada M, Tateishi M, Ando H, Fujimura A. Chronopharmacology of angiotensin II–receptor blockers in stroke-prone spontaneously hypertensive rats. Journal of pharmacological sciences. 2011:1101240507-.10.1254/jphs.10284FP21282930
  14. [14] Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. Journal of hypertension. 2002 Nov 1;20(11):2183-9.10.1097/00004872-200211000-0001712409956
  15. [15] Portaluppi F, Lemmer B. Chronobiology and chronotherapy of ischemic heart disease. Advanced drug delivery reviews. 2007 Aug 31;59(9-10):952-65.10.1016/j.addr.2006.07.02917675179
  16. [16] Portaluppi F, Tiseo R, Smolensky MH, Hermida RC, Ayala DE, Fabbian F. Circadian rhythms and cardiovascular health. Sleep medicine reviews. 2012 Apr 1;16(2):151-66.10.1016/j.smrv.2011.04.00321641838
  17. [17] Potucek P, Klimas J. Chronotherapy of hypertension with combination treatment. Die Pharmazie-An International Journal of Pharmaceutical Sciences. 2013 Dec 2;68(12):921-5.
  18. [18] Potucek P, Radik M, Doka G, Kralova E, Krenek P, Klimas J. mRNA levels of circadian clock components Bmal1 and Per2 alter independently from dosing time-dependent efficacy of combination treatment with valsartan and amlodipine in spontaneously hypertensive rats. Clinical and Experimental Hypertension. 2017 Nov 17;39(8):754-63.10.1080/10641963.2017.132448028665713
  19. [19] Qiu YG, Chen JZ, Zhu JH, Yao XY. Differential effects of morning or evening dosing of amlodipine on circadian blood pressure and heart rate. Cardiovascular drugs and therapy. 2003 Jul 1;17(4):335-41.
  20. [20] Salles GF, Reboldi G, Fagard RH, Cardoso CR, Pierdomenico SD, Verdecchia P, Eguchi K, Kario K, Hoshide S, Polonia J, de la Sierra A. Prognostic effect of the nocturnal blood pressure fall in hypertensive patients: the ambulatory blood pressure collaboration in patients with hypertension (ABC-H) meta-analysis. Hypertension. 2016 Apr;67(4):693-700.10.1161/HYPERTENSIONAHA.115.0698126902495
  21. [21] Schillaci G, Battista F, Settimi L, Schillaci L, Pucci G. Antihypertensive drug treatment and circadian blood pressure rhythm: a review of the role of chronotherapy in hypertension. Current pharmaceutical design. 2015 Feb 1;21(6):756-72.10.2174/138161282066614102413001325341857
  22. [22] Shiga T, Fujimura A, Tateishi T, Ohashi K, Ebihara A. Differences of chronopharmacokinetic profiles between propranolol and atenolol in hypertensive subjects. The Journal of Clinical Pharmacology. 1993 Aug;33(8):756-61.10.1002/j.1552-4604.1993.tb05620.x8408738
  23. [23] Smolensky MH, Hermida RC, Ayala DE, Tiseo R, Portaluppi F. Administration–time-dependent effects of blood pressure-lowering medications: basis for the chronotherapy of hypertension. Blood pressure monitoring. 2010 Aug 1;15(4):173-80.10.1097/MBP.0b013e32833c730820571367
  24. [24] Takeda N, Maemura K. Circadian clock and cardiovascular disease. Journal of cardiology. 2011 May 1;57(3):249-56.10.1016/j.jjcc.2011.02.00621441015
  25. [25] Wu X, Liu Z, Shi G, Xing L, Wang X, Gu X, Qu Z, Dong Z, Xiong J, Gao X, Zhang C. The circadian clock influences heart performance. Journal of biological rhythms. 2011 Oct;26(5):402-11.10.1177/074873041141416821921294
  26. [26] Zhao P, Xu P, Wan C, Wang Z. Evening versus morning dosing regimen drug therapy for hypertension. Cochrane Database of Systematic Reviews. 2011(10).10.1002/14651858.CD004184.pub2904037721975743
Language: English
Page range: 32 - 36
Submitted on: Jul 3, 2019
Accepted on: Sep 26, 2019
Published on: Jan 28, 2020
Published by: Comenius University in Bratislava, Faculty of Pharmacy
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Related subjects:

© 2020 P. Potucek, J. Klimas, published by Comenius University in Bratislava, Faculty of Pharmacy
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.